| Mesinkovska, Natasha |
| Recruiting | 2 | 68 | US | Dupilumab, Placebo | Emma Guttman, Regeneron Pharmaceuticals | Alopecia Areata | 12/26 | 12/27 | | |
NCT05866562: Dupilumab in the Treatment of Pediatric Alopecia Areata |
|
|
| Recruiting | 2 | 76 | US | Dupilumab, Dupixent, Placebo | Icahn School of Medicine at Mount Sinai | Alopecia Areata | 05/28 | 05/29 | | |
NCT04176068: Combined Focused Ultrasound and Calcium Hydroxylapatitie Filler for Skin Laxity and Volume Restoration |
|
|
| Completed | 1 | 20 | US | calcium hydroxylapatite (Radiesse) and IFUS (Ulthera), intense microfocused ultrasound | University of California, Irvine | Skin Laxity | 12/21 | 12/21 | | |
NCT04800185: Characterizing Skin Microbiome Change in Atopic Dermatitis |
|
|
| Completed | 1 | 20 | US | Crisaborole 2% Top Oint, Skin Microbiome Swabs | University of California, Irvine, Pfizer | Atopic Dermatitis, Atopic Dermatitis Eczema | 04/22 | 04/22 | | |
NCT04969380: SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow |
|
|
| Completed | N/A | 20 | US | Sofwave | Sofwave Medical LTD | Skin Laxity | 02/23 | 02/23 | | |
NCT04530500: COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression |
|
|
| Withdrawn | N/A | 200 | US | COVID-19 Androgen Sensitivity Test (CoVAST) | University of California, Irvine, Applied Biology, Inc. | Covid19, Androgen Receptor Gene Overexpression | 12/21 | 12/23 | | |
| Recruiting | N/A | 15000 | Europe, Canada, US | | Target PharmaSolutions, Inc. | Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria | 12/50 | 12/50 | | |
| Yale, Katerina |
| No trials found |
